477 filings
8-K
MSLPQ
MusclePharm Corp
31 Aug 23
Departure of Directors or Certain Officers
5:23pm
8-K
MSLPQ
MusclePharm Corp
19 Jul 23
Departure of Directors or Certain Officers
3:06pm
8-K
MSLPQ
MusclePharm Corp
10 Mar 23
Departure of Directors or Certain Officers
4:16pm
8-K
MSLPQ
MusclePharm Corp
11 Jan 23
Bankruptcy or Receivership
5:02pm
8-K
MSLPQ
MusclePharm Corp
10 Jan 23
Changes in Registrant's Certifying Accountant
7:37pm
8-K
4r9fhc8qba
9 Jan 23
Bankruptcy or Receivership
2:41pm
8-K
wegqutwnzhbf u2a
29 Sep 22
Departure of Directors or Certain Officers
4:33pm
8-K
dsh1u77d2u6h2v731
16 Sep 22
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
5:43pm
8-K
piok4s3dumse82onj1
23 Aug 22
Departure of Directors or Certain Officers
4:53pm
8-K
gooud5v
22 Aug 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:09pm
NT 10-Q
g94qrtppabnt2 bch
16 Aug 22
Notice of late quarterly filing
5:54pm
8-K
10yobzp
28 Jul 22
Departure of Directors or Certain Officers
4:30pm
8-K
pmx227rvb vif
12 Jul 22
Departure of Directors or Certain Officers
5:00pm
8-K
m7my6r2a
22 Jun 22
Departure of Directors or Certain Officers
4:05pm
8-K
brp8 upipei
14 Jun 22
Entry into a Material Definitive Agreement
4:10pm
8-K
smwmlqrsh5gyk7ffqxe0
9 Jun 22
Entry into a Material Definitive Agreement
4:27pm
8-K
819znov3efs3o9h2s5dn
17 May 22
MusclePharm Announces First Quarter 2022 Financial Results
4:15pm
8-K
7dljo1fedecpz9kqyc
5 May 22
Company Delivers $10.0 Million of Net Revenue in Fourth Quarter 2021 and $50.0 Million of Net Revenue for Full Year 2021
4:55pm